Top 28 Raze Therapeutics investors
The most complete profiles first. Showing 28 of 28.
Jernej GodecVerified
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Verified email available
Kevin BittermanVerified
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 70 more
Verified email available
Meredith FisherVerified
Venture Capital, Investor · United States
SeedHealth CareWellnessWomen FoundedLife SciencePortfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more
Verified email available
Noga YerushalmiVerified
Venture Capital, Corporate Venture Capital, Private Equity Firm · Israel
SeedHealth CareConsumer GoodsInfrastructureLife SciencePortfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more
Verified email available
Owen LozmanVerified
Venture Capital, Corporate Venture Capital, Private Equity Firm · Netherlands
SeedHealth CareConsumer GoodsInfrastructureLife SciencePortfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more
Verified email available
Roger KittermanVerified
Venture Capital, Investor · United States
SeedHealth CareWellnessWomen FoundedLife SciencePortfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more
Verified email available
Peter BarrettVerified
Venture Capital, Private Equity Firm, Angel/Individual · United States
SeedSeries BSeries AHealth CareAutonomous VehiclesCybersecurityDeepTechPortfolio: Posterous, Momenta Pharmaceuticals, Synlogic, Cadent Therapeutics and 5 more
Verified email available
Alex HardingVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Verified email available
Brian GoodmanVerified
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Jason RhodesVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Verified email available
Javier RodriguezVerified
Venture Capital, Corporate Venture Capital, Private Equity Firm · Germany
Health CareConsumer GoodsInfrastructureLife SciencePortfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more
Verified email available
Luke EvninVerified
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Shinichiro FuseVerified
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Todd FoleyVerified
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Carl Berke
Venture Capital, Investor · United States
SeedHealth CareWellnessWomen FoundedLife SciencePortfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more
Contact details available
Cheryl Zimberlin
Venture Capital, Corporate Venture Capital, Investor · Netherlands
SeedHealth CareConsumer GoodsInfrastructureLife SciencePortfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more
Contact details available
Christian Patze
Venture Capital, Corporate Venture Capital, Private Equity Firm · Germany
SeedHealth CareDeepTechConsumer GoodsInfrastructurePortfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more
Contact details available
Ed Hurwitz
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, Protego Biopharma, InformedDNA, Mitobridge and 60 more
Contact details available
Stephen Curtis
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Christiana Bardon M.D.
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareGeneticsInvestment ManagementLife SciencePortfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Jean
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Contact details available
Julian Schubert
Venture Capital, Corporate Venture Capital · Germany
Health CareConsumer GoodsInfrastructureChemicalPortfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more
Contact details available
Julius Knowles
Venture Capital, Design Operator, Strategy Operator · United States
Health CareHospitalsWellnessWomen FoundedPortfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more
Contact details available
Leigh Zawel
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Ruoxi Hu
Venture Capital · United States
Health CareWellnessWomen FoundedLife SciencePortfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more
Contact details available
Steven Robinette
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Contact details available
Vinay Bhaskar
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Wallace Wallace
Venture Capital, Corporate Venture Capital · Netherlands
Health CareConsumer GoodsInfrastructureLife SciencePortfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Raze Therapeutics investors are on Angel Roster?
Angel Roster lists 28 Raze Therapeutics investors. 14 of them (50%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (28), Private Equity Firms (15) and Corporate Venture Capital Firms (7). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Raze Therapeutics investors invest in?
Among those that list a stage, the most common are Seed (10), Series B (3) and Series A (1).
Where are Raze Therapeutics investors based?
Most are based in the United States (21), the Netherlands (3) and Germany (3).
Which companies have Raze Therapeutics investors backed?
The most-backed portfolio companies among them are Triplet Therapeutics (20), Translate Bio (18), IOmx Therapeutics (16), Dyne Therapeutics (15) and CoStim Pharmaceuticals (14).
How do I contact Raze Therapeutics investors?
Create a free Angel Roster account to search and filter all 28, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.